Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section

A

Ain Shams Maternity Hospital

Status and phase

Unknown
Phase 4

Conditions

Bleeding

Treatments

Drug: Tranexamic Acid

Study type

Interventional

Funder types

Other

Identifiers

NCT02279186
septemper 2014

Details and patient eligibility

About

In this study, the efficacy and safety of tranexamic acid in the reducing the blood loss during and after elective LSCS will be investigated.

Full description

To state the effectiveness clinically and laboratory and safety of tranexamic acid in reducing blood loss during and after the elective lower segment cesarean section.

Enrollment

200 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

    • Women undergoing caesarean delivery for various elective indications.
  • Full term primiparas / multiparas.
  • Singleton pregnancy being delivered by LSCS.

Exclusion criteria

    • Medical problems involving the heart, liver, kidney and brain .
  • Blood disorders.
  • Allergy to tranexamic acid.
  • History of thromboembolic disorders, abnormal placentation, severe pre-eclampsia, uterine anomalies and pathology.
  • Multiple pregnancy, macrosomia.
  • Polyhydromnios .
  • Patients requiring blood transfusion due to anemia

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

200 participants in 2 patient groups

group A
Active Comparator group
Description:
receiving tranexamic acid
Treatment:
Drug: Tranexamic Acid
group B
No Intervention group
Description:
does not receive tranexamic acid

Trial contacts and locations

1

Loading...

Central trial contact

Mahmoud Shalby, MBBCH; Amr Abdelaziz, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems